Literature DB >> 31669546

Mucosal vaccines: Strategies and challenges.

Miao Li1, Yi Wang1, Yuan Sun1, Hongyu Cui1, Shu J Zhu2, Hua-Ji Qiu3.   

Abstract

Mucosal immunization has potential benefits over conventional parenteral immunization, eliciting immune defense in both mucosal and systemic tissue for protecting from pathogen invasion at mucosal surfaces. To provide a first line of protection at these entry ports, mucosal vaccines have been developed and hold a significant promise for reducing the burden of infectious diseases. However, until very recently, only limited mucosal vaccines are available. This review summarizes recent advances in selected aspects regarding mucosal vaccination, including appropriate administration routes, reasonable formulations, antigen-sampling and immune responses of mucosal immunity, and the strategies used to improve mucosal vaccine efficacy. Finally, the challenges of developing successful mucosal vaccines and the potential solutions are discussed.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Adjuvants; Administration routes; Mucosal immune responses; Mucosal vaccine; Targeted strategies

Mesh:

Substances:

Year:  2019        PMID: 31669546     DOI: 10.1016/j.imlet.2019.10.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  34 in total

1.  Intestinal single-cell atlas reveals novel lymphocytes in pigs with similarities to human cells.

Authors:  Jayne E Wiarda; Julian M Trachsel; Sathesh K Sivasankaran; Christopher K Tuggle; Crystal L Loving
Journal:  Life Sci Alliance       Date:  2022-08-22

Review 2.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

Review 3.  Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies.

Authors:  Sodiq A Hameed; Stephane Paul; Giann Kerwin Y Dellosa; Dolores Jaraquemada; Muhammad Bashir Bello
Journal:  NPJ Vaccines       Date:  2022-06-28       Impact factor: 9.399

Review 4.  Mucosal Vaccination: A Promising Alternative Against Flaviviruses.

Authors:  Rosendo Luria-Pérez; Luis A Sánchez-Vargas; Paola Muñoz-López; Gabriela Mellado-Sánchez
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

Review 5.  COVID-19 vaccine development: milestones, lessons and prospects.

Authors:  Maochen Li; Han Wang; Lili Tian; Zehan Pang; Qingkun Yang; Tianqi Huang; Junfen Fan; Lihua Song; Yigang Tong; Huahao Fan
Journal:  Signal Transduct Target Ther       Date:  2022-05-03

6.  Titrating Polyarginine into Nanofibers Enhances Cyclic-Dinucleotide Adjuvanticity in Vitro and after Sublingual Immunization.

Authors:  Sean H Kelly; Benjamin J Cossette; Ajay K Varadhan; Yaoying Wu; Joel H Collier
Journal:  ACS Biomater Sci Eng       Date:  2021-03-27

7.  Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs.

Authors:  Sankar Renu; Ninoshkaly Feliciano-Ruiz; Veerupaxagouda Patil; Jennifer Schrock; Yi Han; Anikethana Ramesh; Santosh Dhakal; Juliette Hanson; Steven Krakowka; Gourapura J Renukaradhya
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

Review 8.  Demystifying particle-based oral vaccines.

Authors:  Pedro Gonzalez-Cruz; Harvinder Singh Gill
Journal:  Expert Opin Drug Deliv       Date:  2021-07-06       Impact factor: 8.129

9.  Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity.

Authors:  Kristen M Holland-Tummillo; Lauren E Shoudy; Donald Steiner; Sudeep Kumar; Sarah J Rosa; Prachi Namjoshi; Anju Singh; Timothy J Sellati; Edmund J Gosselin; Karsten Ro Hazlett
Journal:  Pathogens       Date:  2020-05-14

Review 10.  New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan.

Authors:  Roxana Popescu; Mihaela Violeta Ghica; Cristina-Elena Dinu-Pîrvu; Valentina Anuța; Dumitru Lupuliasa; Lăcrămioara Popa
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.